From Genesis to Execution
Genesis is an early-stage investor in medical device technology. We are differentiated through our deep level of engagement in delivering value through all stages of the commercialization process.
This is accomplished by leveraging the time, talent, and financial resources of the Genesis Innovation Group Portfolio.
This is where we find and create the concepts that represent the beginnings of solutions to unsolved problems.
Through the smart deployment of talent and resources, we confirm or query whether further investment is a great opportunity.
Fortunately, we have the talent, experience, and know-how to turn fully developed innovations into valuable assets.
Further investment in the best of our innovations and findings at the early stages can lead to outsized returns due to our highly operational engagement.
With more than 200 patents and innovations among its founders, Genesis Innovations Group is a leader in medical device development and commercialization.
R. Sean Churchill, MD, MBA
Our mission is to significantly improve access to scoliosis screening while saving cost for all stakeholders.
Mg is a common element in the body and breaks down through a natural degradation process as it is absorbed and is removed from the body (more natural compared to hydrolysis of biocomposite / similar materials). Mg allows for many engineering advantages due to its high strength.
This exclusive and proprietary magnesium technology provides optimal characteristics not found in existing soft tissue fixation devices, including high strength, controlled absorption, while promoting regrowth of host tissue. The method of manufacturing provides mechanical strength at least 2X that of PEEK, a well-known performance polymer used in similar indications.
The SafKan OtoSet is the first automated and wearable cerumen removal device.
Building Deep Relationships
Built on trust, with a long history of successful ventures
“Genesis played an integral role in developing the strategy for my company. Together with additional investment of time, talent, and money by Genesis, Imascap has grown beyond my expectations.”Jean Chaoui PhDCEO - Imascap SAS
“Wakestream has invested along side Genesis in two of their portfolio companies because we have come to appreciate the depth of experience of the talent at Genesis and their highly innovative approach to business.”Mike DeVriesChief Investment Officer - Wakestream Ventures
“I sought to leverage the value of my IP for years and struggled to get traction. Genesis engaged my project and within a year they did everything they said they would do, and the result was everything I hoped.”Stephen Gunther, MDCharlottesville, VA
“After being here (2019 The State of Spine Surgery Think Tank) I’m even more glad to have partnered with Genesis. Your connections, experience, and overall perspective is perfect.”Dr. Ryan RoederFounder and Inventor - HAPPE Spine
“One of the best compliments I can say about Genesis is they have done every aspect of medical startup business, and succeeded at it, multiple times. Their professionalism throughout the vetting process was so far superior to any other group we had worked with. Genesis’ unique approach to investing comes from wearing every hat in the process, allowing them to know exactly where you are, where you want to go, and how to get there. It has been a pleasure working with them.”Chip CorriganCEO - Medical Ingenuities